Absorption, Metabolism, and Excretion Following a Single Oral Dose of [14C]-Rucaparib

NCT02986100 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: C-14 labeled Rucaparib
DRUG: Rucaparib

Sponsor

pharmaand GmbH